| 5 | 1/1 | 返回列表 |
| 查看: 832 | 回復: 5 | |||
| 當前只顯示滿足指定條件的回帖,點擊這里查看本話題的所有回帖 | |||
[交流]
單一和多重過敏呼吸道變應性疾病兒童屋塵螨舌下特異性免疫治療的療效和安全性 已有5人參與
|
|||
|
Background: The efficacy of single-allergen-specific immunotherapy in polysensitized subjects is a matter of debate. This study aimed to investigate the efficacy of house dust mite (HDM) sublingual immunotherapy (SLIT) in monosensitized and polysensitized children. Methods: A total of 112 children, aged 4 to 13 years old, with HDM-induced respiratory allergic diseases were allocated to a monosensitized group (n = 56) or a polysensitized group (n = 56). Both groups were treated by standard pharmacotherapy and SLIT with Dermatophagoides farinae (American HDM) extracts for 52 weeks. Symptoms, medications, visual analogue scale (VAS), and presence of adverse events (AEs) were assessed once a month. Skinprick test (SPT) was done before and aer treatment. After treatment, subjects in the polysensitized group who completed the study were further analyzed as subgroup 1 (n=20) and subgroup 2 (n=15) according to the number of coexisting allergens. Results: Forty-one subjects in the monosensitized group and 35 subjects in the polysensitized group completed the study. The global clinical parameters had significantly improved after treatment, with no significant difference between the monosensitized and polysensitized group throughout this period (all p > 0.05). The comparison among the monosensitized group, subgroup 1, and subgroup 2 indicated that there was no significant difference in symptoms scores and VAS at each scheduled follow-up visit. Therewas also no significant difference in total medications score (TMS) in the monosensitized group, subgroup 1, and subgroup 2 after week 24 (all p > 0.05). No severe systemic AEs were reported. Conclusion: No significant difference was observed in the clinical effects of HDM SLIT between polysensitized and monosensitized children with respiratory allergic diseases. |
|
本帖內(nèi)容被屏蔽 |
|
本帖內(nèi)容被屏蔽 |
|
本帖內(nèi)容被屏蔽 |
|
本帖內(nèi)容被屏蔽 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0817化學工程319求調(diào)劑 +3 | lv945 2026-03-08 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 理學287分求調(diào)劑 +4 | 看看我. 2026-03-05 | 4/200 |
|
|
[考研] 322分 085600求調(diào)劑,有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +4 | 熊境喆 2026-03-05 | 4/200 |
|
|
[考研] 材料工程專碩調(diào)劑自薦信,初試323 +4 | 李白26 2026-03-07 | 4/200 |
|
|
[考研] 070300化學求調(diào)劑292分 +3 | 打烊eee 2026-03-07 | 3/150 |
|
|
[考研] 材料專碩調(diào)劑 +5 | 慕辰123 2026-03-05 | 8/400 |
|
|
[考研] 求調(diào)劑 +4 | 呼呼?~+123456 2026-03-05 | 5/250 |
|
|
[考研] 085701環(huán)境工程295求調(diào)劑,一志愿A區(qū)211 +7 | 等春來, 2026-03-06 | 8/400 |
|
|
[考研] 哈爾濱理工大學2026年研究生調(diào)劑,材料科學與化學工程學院研究生調(diào)劑 +3 | xinliu866 2026-03-06 | 3/150 |
|
|
[考研] 材料考研339求調(diào)劑 +3 | Karry*^_^* 2026-03-04 | 3/150 |
|
|
[考研] 材料085601一志愿哈工大317 +4 | 壓迫感行 2026-03-04 | 4/200 |
|
|
[考研] 一志愿清華深研院材料專碩294分,專業(yè)課111分,本科中南大學材料,有六級,有工作經(jīng)驗 +3 | H14528 2026-03-04 | 3/150 |
|
|
[考研] 281電子信息求調(diào)劑 +5 | jhtfeybgj 2026-03-02 | 9/450 |
|
|
[考研] 材料328求調(diào)劑 +10 | 一個蘿卜02 2026-03-03 | 10/500 |
|
|
[論文投稿]
100+4
|
Stray2021 2026-03-03 | 4/200 |
|
|
[考研] 322分 085600求調(diào)劑,有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +6 | 熊境喆 2026-03-04 | 6/300 |
|
|
[考研] 一志愿鄭州大學,學碩,物理化學, 333求調(diào)劑 +5 | 李魔女斗篷 2026-03-04 | 5/250 |
|
|
[考研] 291求調(diào)劑 +4 | Afy123456 2026-03-03 | 7/350 |
|
|
[考研] 289求調(diào)劑 +7 | BrightLL 2026-03-02 | 9/450 |
|
|
[考研] 一志愿中石油(華東)本科齊魯工業(yè)大學 +3 | 石能偉 2026-03-02 | 3/150 |
|